WSJ's blog on health and the business of health.

Visit WSJ.com: Health Blog

Glaxo Pays $40 Million in (Another) Paxil Settlement

Posted on October 02, 2008

GlaxoSmithKline is shelling out another $40 million to deal with the fallout over the use of its antidepressant Paxil in kids. This time, the money is going to insurers who paid for the drug to be used in children and adolescents.A class-action lawsuit argued that Glaxo had promoted the drug for use in children, while withholding evidence that the drug was neither safe nor effective in kids. Glaxo denied those charges and told the WSJ it settled to avoid the costs, burdens and uncertainties of ongoing litigation. The whole Paxil and kids thing has been a long-running problem for Glaxo. La...

Original article link


adolescents , antidepressant , children , kids , running